The supplied articles do not contain information about Affluent Medical. Instead, they detail Carvolix, a medical-technology company that is deploying a robotic platform called Tavipilot and other products (Kalios, Artus, Artedrone, Mitrapilot). Carvolix used the €10.0M strategic placement to bolster cash to €20.0M, fund product development and repay bridge financing, and it plans regulatory submissions and clinical milestones through late 2026. If you intended a memo on Affluent Medical, please provide the articles or sources about Affluent Medical and I will prepare the requested deal memo.

Total raised

$29M

Funding rounds

3

Latest round

Equity

Latest activity

Jun 2026